Tenvie Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- January 08, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $200,000,000
Company Info
- Company Description
- Tenvie Therapeutics is committed to transforming the treatment of neurological diseases by leveraging a deep and diverse portfolio of small molecule assets, including programs acquired from Denali Therapeutics Inc., supported by a proven team of research and development leaders.
- Market
- Neurological diseases
- Location
- South San Francisco, California, USA
- Coinvestors
- ARCH Venture Partners, F-Prime Capital, Mubadala Capital